Sensor success

Southampton University spin-out Stratophase has secured £2m in contracts over the past year, allowing it to access a rapidly growing sensor market using its biochemical measurement and detection technology.

The company hopes that its patented biochemical sensor featuring optical microchips will pave the way in increasing its market share.

The SpectroSens device is able to detect all classes of biological targets, including proteins, toxins, viruses and bacteria, as well as measuring changes in the chemical composition of liquids.

The market for chemical sensors is forecast to grow considerably in the next few years. Stratophase believes that its technical developments in enabling miniaturisation and increasing cost efficiency will allow it to make the most of these opportunities.

Over the past year Stratophase has increased its in-house capabilities, upgraded its bio-assay development facility and advanced its integrated optical chip development and production activities. In addition, it has increased its workforce to support the development of its SpectroSens device.